左心室辅助装置植入后疾病特异性与通用健康状态测量的变化:INTERMACS 研究启示
该研究基于 INTERMACS 注册库,分析 2012 至 2014 年 1,888 例晚期心衰患者 LVAD 植入后 6 个月 KCCQ 与 VAS 的变化,平均改善分别为 32.7±25.0 和 27.6±27.4。在 KCCQ 中度/大幅改善的 1,539 例(81.5%)中,334 例(21.7%)VAS 未同步显著升高,基线 VAS 评分是最强预测因素,而术后并发症无显著预测作用。
要点
- LVAD 后多数患者心衰特异性与通用生活质量均显著改善。
- KCCQ 改善者中约 21.7% 的 VAS 未同步显著升高,不一致不常见。
- 基线 VAS 较高者更易出现 KCCQ-VAS 不一致,术后并发症无显著预测作用。
核心结论
- LVAD 植入后多数患者心衰特异性与通用生活质量均大幅改善,两者不一致并不常见。
- 不一致主要见于术前 VAS 已报告良好通用生活质量的患者。
- 结果支持继续使用心衰特异性健康状态量表监测 LVAD 前后生活质量。
研究设计与样本
- 基于 INTERMACS 注册库的回顾性分析,纳入 2012 至 2014 年 1,888 例接受 LVAD 植入的晚期心衰患者。
- 分别用 KCCQ 评估心衰特异性生活质量、EuroQol-5D VAS 评估通用生活质量。
主要发现
- LVAD 后 6 个月 KCCQ 与 VAS 平均变化分别为 32.7±25.0 和 27.6±27.4。
- KCCQ 中度/大幅改善的 1,539 例(81.5%)中,334 例(21.7%)VAS 未同步显著升高。
- 多变量 logistic 回归中基线 VAS 评分是 KCCQ-VAS 不一致的最强预测因素。
- 术后 LVAD 并发症不是不一致的显著预测因素。
临床怎么用
- LVAD 前后应继续使用 KCCQ 等心衰特异性量表监测生活质量变化。
- 对术前 VAS 已较高的患者,需注意 KCCQ 改善可能不伴随 VAS 同步升高。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Quantifying quality of life (QoL) after left ventricular assist device (LVAD) remains challenging. Heart failure (HF)-specific health status measures are ideal for assessing symptoms of HF; however, if patients' QoL is limited by other factors, they may experience improved HF-specific QoL but no concurrent improvement in generic QoL. We sought to examine and predict discrepancies between disease-specific and generic QoL measures after LVAD. METHODS: We examined HF-specific and generic QoL with the Kansas City Cardiomyopathy Questionnaire (KCCQ) and EuroQol-5D Visual Analog Scale (VAS), respectively, among 1,888 patients with advanced heart failure who underwent LVAD implantation from 2012 to 2014 as part of the INTERMACS registry. RESULTS: Both measures showed substantial improvement, on average, at 6 months after LVAD, with mean changes of 32.7 ± 25.0 and 27.6 ± 27.4, respectively. Among the 1,539 patients (81.5%) with moderate/large improvement in KCCQ, 334 (21.7%) had discordant changes in generic QoL (i.e., VAS did not substantially increase despite improvement in KCCQ). In a multivariable logistic regression model, baseline VAS score was the strongest predictor of KCCQ-VAS discordance, whereas post-LVAD complications were not significant predictors of discordance. CONCLUSIONS: Most patients have major improvements in both HF-specific and generic QoL after LVAD implantation, and discordance in these measures after LVAD is uncommon. When it did occur, discordance was primarily observed in patients who reported good generic QoL on the VAS before LVAD (despite substantial impairment due to congestive HF). These results support the continued use of HF-specific health status measures to monitor QoL before and after LVAD implantation.
引用
- Nassif ME, Spertus JA, Jones PG, et al. Changes in disease-specific versus generic health status measures after left ventricular assist device implantation: Insights from INTERMACS. J Heart Lung Transplant. 2017. PMID: 28662987. doi:10.1016/j.healun.2017.05.023
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。